07:00 , Mar 13, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Renal diseasew

Indication Target/marker/pathway Summary Licensing status Publication and contact information Renal diseasew Renal disease Adenosine A3 receptor (ADORA3) In vitro and cell-based studies identified an ADORA3 partial agonist that could help treat kidney disease caused by...